ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,748, issued on Feb. 18, was assigned to KING SAUD UNIVERSITY (Riyadh, Saudi Arabia).
"Aptamers for binding to a membrane-based lipid" was invented by Md. Ashrafuzzaman (Riyadh, Saudi Arabia).
According to the abstract* released by the U.S. Patent & Trademark Office: "A lipid-binding drug for binding to a membrane-based or membrane lipid comprises at least one aptamer having a sequence selected from the group consisting of GGCGGCAAAAAAAAAA (SEQ ID NO: 1), GGCGGCAAAAAAAAAAA (SEQ ID NO: 2), GGCGGCAAAAAAAAAAAA (SEQ ID NO: 3), GGCGGCAAAAAAAAAAAAA (SEQ ID NO: 4), GGCGGCGGGGGGGGGG (SEQ ID NO: 5), GGCGGCGGGGGGGGGGG (SEQ ID NO: 6), GGCGGCGGGGGGGGGGG (SEQ ID NO: 7), GGCGGCGGGGGGGGGGG (SEQ ...